Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/4LN2 stock hub

FRA/4LN2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4LN2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/4LN2FRA/4LN2

—

Loading chart…

In the news

Latest news · FRA/4LN2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-46.6

P25 n/aP50 n/aP75 n/a

ROIC-28.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4LN2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

USD

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	231
Employees Change	71%
Employees Change Percent	44.38
Enterprise value	EUR 1.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.5B
Price	EUR 24.67
Price currency	EUR
Sic	2836
Symbol	fra/4LN2
Website	https://www.capricor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.99%
EV Earnings	-13.8x
EV/FCF	-17.78x
FCF yield	-4.65%
P/B ratio	5.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -71.9M
Net Income	EUR -89.5M
Profit Per Employee	EUR -387,298
ROA	-25.68
Roa5y	-30.32
ROCE	-33.78
ROE	-46.56
Roe5y	-85.21
ROIC	-28.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	285.22%
Cagr3y	94.43%
Cagr5y	53.88%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 303.2M
Cash	EUR 271M
Current Assets	EUR 273.8M
Current Liabilities	EUR 30.4M
Debt	EUR 12.4M
Debt Equity	EUR 0.05
Debt FCF	EUR -0.18
Equity	EUR 260.4M
Interest Coverage	-35.51
Liabilities	EUR 42.7M
Long Term Assets	EUR 29.3M
Long Term Liabilities	EUR 12.3M
Net Cash	EUR 258.6M
Net Cash By Market Cap	EUR 17.32
Net Cash Growth	102.32%
Net Debt Equity	EUR -0.99
Tangible Book Value	EUR 260.4M
Tangible Book Value Per Share	EUR 4.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.01
Net Working Capital	EUR -26.3M
Quick ratio	8.88
Working Capital	EUR 244.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	284.87%
200-day SMA	13.45
3Y total return	635.32%
50-day SMA	23.97
50-day SMA vs 200-day SMA	50over200
5Y total return	762.59%
All Time High	30.1
All Time High Change	-18.04%
All Time High Date	2026-03-11
All Time Low	0.82
All Time Low Change	2,908.54%
All Time Low Date	2020-03-10
ATR	1.31
Ch YTD	-0.92
High	25.87
High52	30.1
High52 Date	2026-03-11
High52ch	-18.04%
Low	24.28
Low52	3.73
Low52 Date	2025-11-25
Low52ch	561.39%
Ma50ch	2.91%
Price vs 200-day SMA	83.42%
RSI	46.9
RSI Monthly	64.22
RSI Weekly	64.42
Sharpe ratio	1.05x
Sortino ratio	4.81
Total Return	-31.97%
Tr YTD	-0.92
Tr1m	-7.91%
Tr1w	-3.82%
Tr3m	30.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -92.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,885,171%
Shares Insiders	1.02%
Shares Institutions	45.14%
Shares Qo Q	6.86%
Shares Yo Y	31.97%
Short Ratio	7.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -84.1M
Average Volume	25x
Bv Per Share	4.54
CAPEX	EUR -10M
Ch1m	-7.91
Ch1w	-3.82
Ch1y	284.9
Ch3m	30.39
Ch3y	635.3
Ch5y	762.6
Ch6m	373.5
Change	-11%
Change From Open	-4.64
Close	27.72
Days Gap	-6.67
Depreciation Amortization	1,601,835
Earnings Date	2026-05-12
EBIT	EUR -92.1M
EBITDA	EUR -90.5M
EPS	EUR -1.92
F Score	2
FCF	EUR -69.4M
FCF EV Yield	-5.62x
Financing CF	211,981,569
Fiscal Year End	December
Founded	2,005
Income Tax	EUR 1,363
Investing CF	83,023,104
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Last Split Date	2019-06-05
Last Split Type	Reverse
Ma150	15.81
Ma150ch	56.04%
Ma20	25.8
Ma20ch	-4.36%
Net CF	235,546,421
Next Earnings Date	2026-05-12
Open	25.87
Position In Range	24.53
Ppne	27,007,638.9
Price Date	2026-05-08
Ptbv Ratio	5.73
Relative Volume	2,000x
Share Based Comp	14,670,754
Tr6m	373.51%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/4LN2 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/4LN2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4LN2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+45.1%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/4LN2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.9

Neutral momentum band

Price vs 200-day MA

+83.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4LN2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4LN2 stock rating?

fra/4LN2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4LN2 analysis?

The full report lives at /stocks/fra/4LN2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4LN2?

The latest report frames fra/4LN2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4LN2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.